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CASE STUDY
Can titanium mesh influence local 
recurrence management after implant-based 
breast reconstruction?
Egidio Riggio1*, Camelia Chifu2, Gabriele Martelli2 and Cristina Ferraris2
Abstract 
Introduction: TiLOOP® Bra is a permanent titanium-coated polypropylene mesh currently used in post-mastectomy 
breast reconstruction with implants. This mesh is generally presented as inducing low-grade inflammatory reactions, 
but only few reports focused on its possible side effects. In the case described here, the use of the mesh led to minor 
clinical problems that needed to be clinically and surgically managed at the same time as a local relapse.
Case description: A patient with high-grade ductal carcinoma in situ underwent primary surgery (nipple-sparing 
mastectomy and one-stage reconstruction using the TiLOOP® Bra mesh) and was subsequently referred for radiologi-
cal and clinical investigation when various nodules became apparent during a follow-up physical examination. Prior 
to the histopathological proof, the diagnosis of local recurrence was complicated by the occurrence of an extensive 
granulomatous reaction in the fixation areas along with mild inflammatory changes scattered on the surface of the 
mesh.
Discussion and evaluation: This case illustrates a side effect of titanium-coated permanent mesh in immediate 
implant-based reconstruction, i.e. the formation of granulomas in the inframammary fold, probably in the area where 
the mesh had been folded or fixed. We propose a safer technical approach to avoid the problem and a clinical man-
agement strategy for patients at high risk of local recurrence who develop granuloma-like nodules.
Conclusions: A surgical technique is suggested to prevent granuloma formation. If, however, subcutaneous nodules 
that may be local recurrences do appear, they should not be interpreted by default as a granulomatous reaction, but 
should be fully investigated and possibly excised.
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Introduction
In recent years, manufacturers have created new prod-
ucts for breast reconstruction, some of them made of 
expensive biological materials, such as the acellular der-
mal matrix meshes, and others consisting of more afford-
able synthetic materials such as the titanium-coated 
polypropylene mesh. This mesh is increasingly used in 
Europe because of its satisfactory quality and cost-effec-
tiveness and is generally presented as inducing low-grade 
inflammatory reactions, but  only few reports have dis-
cussed its performance.
This case report describes the clinical problems that 
occurred in the treatment of a young patient affected by 
ductal carcinoma in situ (DCIS), who after a nipple-spar-
ing mastectomy underwent immediate implant-based 
reconstruction using a TiLOOP® Bra mesh (pfm medical, 
Cologne, Germany).
Case description
In January 2012, a 27-year-old patient presented with a 
palpable mass of micronodules in the upper-outer quad-
rant of the right breast. Two years previously, she had 
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undergone bilateral breast augmentation by subglandular 
access with a round Allergan CML implant (265 cc). No 
noteworthy medical conditions, risk factors or familial 
breast cancer history were reported.
A focused ultrasound scan found an area of increased 
glandular density while mammography showed 15  mm 
microcalcifications in the suspicious area. Breast MRI 
confirmed pathological contrast enhancement. The 
lesion was diagnosed as high-grade DCIS by histologi-
cal examination after vacuum-assisted biopsy. Nipple-
sparing mastectomy with sentinel lymph node biopsy 
and immediate implant-based reconstruction were per-
formed in March 2012.
The patient’s subcutaneous layer was very thin and 
post-mastectomy skin flaps were less than 5  mm. The 
pectoralis major muscle was elevated by dividing the 
lower and medial insertions, and a TiLOOP® Bra mesh 
was placed inferiorly and laterally in order to complete 
the pocket. The lower edge was fixed along the inframam-
mary fold with single absorbable 3-0 sutures. The patho-
logical diagnosis confirmed high-grade comedo-type 
DCIS (ER-positive, PgR-positive, Her2-negative). The 
nipple and sentinel lymph node biopsies were negative. 
No adjuvant therapies were recommended.
After a mastectomy, we schedule physical examina-
tion and breast ultrasound every 6  months and mam-
mography once a year. MRI is used for patients with 
unclear ultrasound or mammography, with a family his-
tory of breast cancer or BRCA 1/2 mutation. In the pre-
sent case, during a follow-up examination in December 
2012 a palpable nodule was detected in the parasternal 
inframammary crease. Ultrasonography showed a 5-mm 
hypoechoic nodule consistent with granuloma, together 
with reactive axillary lymph nodes (Fig.  1, left). MRI in 
addition showed small areas of non-specific enhance-
ment over the implant, particularly in the subcutaneous 
layer of the lower-inner quadrant, but did not reveal any 
distinct nodules. An MRI scan was planned 8 weeks later 
and clinical examination 12 weeks later. In February 2013, 
MRI showed decreased enhancement over the implant 
and the development of a new 8 × 3 mm area of homo-
geneous contrast enhancement in the upper-outer right 
quadrant, the site of the primary tumor. It also showed 
another nodule (<5 mm) in the lower-inner quadrant, at 
a distance of 2 cm from the first nodule (Fig. 2). After a 
focused ultrasound scan (Fig.  1, right), a wide excision 
of the upper-outer skin was performed in March and 
revealed a 2-cm multifocal comedo-type DCIS having 
the same biological profile as the primary tumor: ER-
positive, PgR-positive, Her2 negative. In agreement with 
the plastic surgeon, the 5-mm- and <5  mm nodules in 
the inframammary area were not removed at the time, 
because they were suggestive of granuloma.
Afterwards, a PET–CT scan showed minor uptake sug-
gesting the presence of residual pathological tissue within 
the same upper-outer area over the implant. No patho-
logical uptake was observed in the axillary lymph nodes 
or other organs. Although ultrasound imaging suggested 
granuloma as the initial diagnostic hypothesis, the con-
currence with confirmed local recurrence, the limita-
tions of PET–CT diagnostic resolution (5 mm), and the 
infiltration by multiple small nodules prompted a fur-
ther interventional procedure. In April 2013 further sur-
gery was performed to expand the soft-tissue resection 
in the upper-outer quadrant and remove the two suspi-
cious palpable nodules in the medial submammary area. 
The capsular and inner mesh envelope were included in 
the excision (Fig. 3). The frozen sections showed fibrosis 
Fig. 1 Ultrasound images. Left December 2012—the single nodule suggestive of granuloma in the lower-inner quadrant. Right March 2013—the 
nodule in the upper-outer quadrant, positive for recurrent DCIS
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and chronic inflammation with granulomatous reaction 
(Fig. 4).
Discussion and evaluation
Our case report discusses two issues: first a biological 
one, i.e. the development of a chronic granulomatous 
reaction, its prevalence, and how to avoid it; secondly, an 
oncological issue, i.e. the challenge posed by the devel-
opment of multiple nodules in a context of high risk or 
actual occurrence of local relapse.
TiLOOP® Bra is a titanium-coated lightweight polypro-
pylene mesh, approximately 0.2 mm thick and with good 
biocompatibility. The product induces a light inflamma-
tory reaction and no side effect have been reported so far.
The proliferation of inflammatory cells and giant cells 
at the fixation points observed in our case could have 
been triggered by the relatively thick layers of folded 
mesh. From 2012 to 2014, we performed about 50 
implant reconstructions with TiLOOP® Bra. Apart from 
the present case, only one case was observed where a 
granulomatous nodule was located in the inner quadrant, 
but MRI ruled out the possibility of local recurrence. 
This amounts to an incidence of 4  %, which is not low. 
But even if this side effect may be sporadic and not sig-
nificantly interfere with the follow-up of breast cancer 
patients it is important to be aware of its possibility.
The occurrence of mesh-related granuloma can be 
more easily detected in patients with extremely thin 
skin flaps. Among the few reports that have been pub-
lished on titanium meshes, fewer still discussed the 
thickness of the mastectomy flaps and/or the technique 
used in the fixation of the mesh. Dieterich et al. (2013) 
argue that the mesh is minimally palpable and causes 
no discomfort, even when the mastectomy flaps are 
Fig. 2 MRI images, February 2013. Left the first nodule (suggestive of granuloma) in the lower-inner quadrant. Center the nodule at the inframam-
mary fold, at a distance of 2 cm from the first nodule. Right the nodule in the upper-outer quadrant (suggestive of breast cancer recurrence)
Fig. 3 Left after the skin removal, the harvest of the outer fibrous layer above the tissue-integrated titanium mesh. Right the harvest of the inner 
layer composed of capsular tissue and tissue-integrated mesh layer
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very thin. In general, the thickness of mastectomy flaps 
does not influence the success of the implant performed 
using TiLOOP® Bra mesh. Nevertheless, in the absence 
of subcutaneous tissue, biological meshes (acellular der-
mal matrix) are preferred to TiLOOP® Bra, which might 
explain the lack of reports on complications in patients 
with very thin flaps. In a paper that does not report any 
granuloma formation, Riggio et  al. describe how the 
extreme pliability of the titanium mesh can also indi-
rectly generate rippling, as happened to a patient with 
bilateral direct-to-implant reconstruction in the breast 
reconstruction where the mesh was used as opposed 
to the other breast reconstruction performed with-
out mesh (Riggio et al. 2013). Flaps of thin to medium 
thickness cannot completely conceal the presence of the 
TiLOOP® Bra, which can betray itself by dots and/or 
wrinkles. The titanium cover itself should induce mini-
mal capsular reaction. In the case reported here, the 
three midline dots of the implant were almost visible 
between the lightweight mesh and the skin due to the 
thinness of the subcutaneous layer. This was a complica-
tion, however minor, from the surgeon’s point of view, 
even if in general the issue does not influence patients’ 
aesthetic appreciation of the result, as previously 
reported by several authors (Riggio et  al. 2013; Dieter-
ich et al. 2012). Also in this case the patient was entirely 
satisfied with the aesthetic result of surgery (Fig. 5).
To avoid the risk of granuloma formation after imme-
diate breast reconstruction, we advise oncoplastic sur-
geons to fold the lowermost portion of TiLOOP® Bra 
underneath the posterior part of the implant, without 
any wrinkling and with no fixation sutures. If the mesh is 
folded to be stitched along the inframammary fold, it can 
occasionally stimulate extensive granulomatous reaction 
with giant cells, but in the most recent cases where we 
applied the approach with folding only, the complication 
has not been observed.
The oncology issue is more challenging. Subcutane-
ous nodules of different origin forming at the same time 
and with the same clinical features have uncertain differ-
ential diagnosis due to their small size. In our case, the 
concurrent detection of two granuloma-like nodules and 
one nodule which was in fact a local recurrence required 
significant changes in the scheduled surveillance exami-
nations (ultrasound, MRI and PET were performed 
2–3  months after the mastectomy). Just by promptly 
carrying out multiple radiological investigations, the 
Fig. 4 Histological features of the first nodule suggestive of granu-
loma, 14 months after implantation of the TiLOOP® Bra mesh. Paraffin 
section of the subcutaneous tissue specimen, magnification ×10, 
H&E staining: mild infiltration with inflammatory cells and extensive 
granulomatous reaction with giant cells
Fig. 5 The patient after the excisional biopsies. The arrow shows the excision site of the TiLOOP® Bra granuloma. One-stage reconstruction of the 
right breast was performed 19 months before (2012) with an Allergan anatomical and extra-projected implant, 410 FX 360 g. In the left breast, a 
subglandular Allergan CML round 265 cc implant was still present. Capsular reaction was grade 1 according to Baker’s classification on both sides. 
Note the different impact of rippling in the right breast due to the minimal capsular contracture of the implant coverage and the skin and muscle 
atrophy in the upper pole
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oncological diagnosis was not delayed by the presence of 
granulomas, while the only drawback for the patient was 
the number of open biopsies.
In the last two decades the incidence of DCIS has 
increased from 2  % to 15–20  % mainly as a result of 
increased mammographic screenings (Bleicher 2013; 
Owen et  al. 2013), which in turn caused a rise in the 
number of nipple-sparing mastectomies and immediate 
reconstructions performed using products such as the 
titanium-coated mesh. Breast surgeons should be par-
ticularly vigilant with patients at high risk of early local 
recurrence of DCIS and inform plastic surgeons before 
reconstructive surgery is performed, because complete 
resection of the breast parenchyma is virtually impossible 
and, as has been noted, even with meticulous dissection 
under the skin, and also after radical mastectomy (Drea-
din et al. 2012).
In general, when using a permanent fine mesh like 
TiLOOP® Bra, the possible formation of granulomas 
should be taken into account. If a granuloma should be 
suspected, we suggest that resection is advisable unless 
the granulomatous reaction is confirmed by ultrasound 
and MRI and occurs in sites compatible with mesh fold-
ing. In case of patients at high risk of local recurrence, 
preventive resection may be advisable.
Conclusions
It is known that titanium-coated meshes induce mild 
inflammation but our case showed it also can induce late 
granulomatous reactions in vivo. The pliability and thin-
ness of TiLOOP® Bra is generally considered an advan-
tage, but this may not be the case in all patients. Future 
clinical studies should investigate if the use of TiLOOP® 
Bra is consistently associated with granulomatous reac-
tion, or whether the reaction is associated with specific 
technical approaches or patient peculiarities. Meanwhile, 
if reconstruction is performed with a titanium-coated 
mesh, as a preventive measure we suggest avoiding mesh 
fixation and, in selected patients, we advise evaluating 
alternative techniques or products (biological substitutes, 
e.g. acellular dermal matrix). Finally, if nodules should 
appear and there is a risk of local recurrence, further 
clinical investigation is needed or possibly surgical exci-
sion of the nodules.
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